OBJECTIVE: To develop a model estimating the probability of an adult patient having severe functional limitations 2 months after being hospitalized with one of nine serious illnesses. DESIGN: Prospective cohort study. SETTING: Five teaching hospitals in the United States. PARTICIPANTS: 1746 patients (model development) who survived 2 months and completed an interview, selected from 4301 patients in the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT); independent validation sample of 2478 patients. MEASUREMENTS AND MAIN OUTCOMES: Patient function 2 months after admission categorized as absence or presence of severe functional limitations (defined as Sickness Impact Profile scores > or = 30 or as activities of daily living scores > or = 4 [levels that require near-constant personal assistance]). A logistic regression model was constructed to predict severe functional limitation. RESULTS: One third (n = 590) of patients who were interviewed at 2 months had severe functional limitations. Changes in functional status were common: Of those with no baseline dependencies (not dependent on personal assistance), 21% were severely limited at 2 months; of those with 4 or more baseline limitations, 30% had improved. The patient's ability to do activities of daily living was the most important predictor of functional status. Physiologic abnormalities, diagnosis, days in hospital, age, quality of life, and previous exercise capacity also contributed substantially. Model performance, assessed using receiver-operating characteristic curves, was 0.79 for the development sample and 0.75 for the validation sample. The model was well calibrated for the entire risk range. CONCLUSIONS: Functional outcome varied substantially after hospitalization for a serious illness. A small amount of readily available clinical information can estimate the probability of severe functional limitations.
OBJECTIVE: To develop a model estimating the probability of an adult patient having severe functional limitations 2 months after being hospitalized with one of nine serious illnesses. DESIGN: Prospective cohort study. SETTING: Five teaching hospitals in the United States. PARTICIPANTS: 1746 patients (model development) who survived 2 months and completed an interview, selected from 4301 patients in the Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatments (SUPPORT); independent validation sample of 2478 patients. MEASUREMENTS AND MAIN OUTCOMES: Patient function 2 months after admission categorized as absence or presence of severe functional limitations (defined as Sickness Impact Profile scores > or = 30 or as activities of daily living scores > or = 4 [levels that require near-constant personal assistance]). A logistic regression model was constructed to predict severe functional limitation. RESULTS: One third (n = 590) of patients who were interviewed at 2 months had severe functional limitations. Changes in functional status were common: Of those with no baseline dependencies (not dependent on personal assistance), 21% were severely limited at 2 months; of those with 4 or more baseline limitations, 30% had improved. The patient's ability to do activities of daily living was the most important predictor of functional status. Physiologic abnormalities, diagnosis, days in hospital, age, quality of life, and previous exercise capacity also contributed substantially. Model performance, assessed using receiver-operating characteristic curves, was 0.79 for the development sample and 0.75 for the validation sample. The model was well calibrated for the entire risk range. CONCLUSIONS: Functional outcome varied substantially after hospitalization for a serious illness. A small amount of readily available clinical information can estimate the probability of severe functional limitations.
Authors: Brigitte C Beuks; Aafke C Nijhof; John H J M Meertens; Jack J M Ligtenberg; Jaap E Tulleken; Jan G Zijlstra Journal: Intensive Care Med Date: 2006-02-25 Impact factor: 17.440
Authors: P D Le Roux; J Cooper; K K Guntupalli; R Silbergleit; J Daily; R Geocadin; C A C Wijman; J I Suarez Journal: Neurocrit Care Date: 2012-02 Impact factor: 3.210
Authors: Brian K Gehlbach; Victor R Salamanca; Joseph E Levitt; Greg A Sachs; Mary Kate Sweeney; Anne S Pohlman; Jeff Charbeneau; Jerry A Krishnan; Jesse B Hall Journal: Am J Crit Care Date: 2011-09 Impact factor: 2.228
Authors: Glenn V Ostir; Ivonne Berges; Yong-Fang Kuo; James S Goodwin; Kenneth J Ottenbacher; Jack M Guralnik Journal: Arch Intern Med Date: 2012-02-27
Authors: R S Phillips; M B Hamel; J M Teno; P Bellamy; S K Broste; R M Califf; H Vidaillet; R B Davis; L H Muhlbaier; A F Connors Journal: J Gen Intern Med Date: 1996-07 Impact factor: 5.128
Authors: Cynthia M Boyd; Michelle Ricks; Linda P Fried; Jack M Guralnik; Qian-Li Xue; Jin Xia; Karen Bandeen-Roche Journal: J Am Geriatr Soc Date: 2009-08-20 Impact factor: 5.562